Key Topics:

Innovative clinical trials designs
Target discovery and novel therapeutics
Disentangling the clinical activity and adverse events of PARPi´s
Incorporation of targeted agents in the treatment of gynecologic cancers
Inmunotherapy for gynecological cancers: hope or hype?
Adoptive cell therapy for gynecologic cancers: From bench to clinic
Predictive models for cytoreduction in ovarian cancer
Endometrial cancer management from conservative options to novel therapeutics
Updates on global surgical trials
Sentinel node mapping alone. A new standard of care in gynecologic cancers

Meeting Directors:

Dr. Francisco Javier de Santiago · MD Anderson Cancer Center Madrid – Hospiten, Spain
Dr. Robert L. Coleman · The University of Texas MD Anderson Cancer Center, Houston, USA
Dr. Raúl Márquez · MD Anderson Cancer Center Madrid – Hospiten, Spain
Dr. Shannon N. Westin · The University of Texas MD Anderson Cancer Center, Houston, USA